Skip to main content
. 2018 Jul 11;8:10432. doi: 10.1038/s41598-018-28706-1

Table 5.

Antibody panels for evaluating the effect of aa468 on neutralizing efficiencies of mAbs.

Antibody Panel Source Coverage
045-051310-2B0653 Human Group 1 and Group 2
SFV005-2G0277 Human Group 1 and Group 2
FI6v313 Human Group 1 and Group 2
CR911412 Human Group 1, Group 2, and influenza B virus HA